SCHEMBL19080125

SCHEMBL19080125

c1ccc(-c2ccc(-c3c4ccccc4c(-c4cccc(-c5cc6ccccc6c6c5oc5cc7ccccc7cc56)c4)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.35
KMT2A Q03164 5/20 0.35
GPR84 Q9NQS5 5/20 0.35
KDM4E B2RXH2 4/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
MPI P34949 1/20 0.35
ALOX5 P09917 2/20 0.34
RECQL P46063 1/20 0.34
ESR1 P03372 2/20 0.33
ESR2 Q92731 2/20 0.33
ADORA3 P0DMS8 2/20 0.33
ADORA2A P29274 2/20 0.33
ADORA1 P30542 2/20 0.33
RAB9A P51151 2/20 0.33
MAOB P27338 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1A2 P05177 1/20 0.33
FYN P06241 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079968 0.93 GPR84 (0.36) MEN1KMT2AGPR84KDM4EALDH1A1
SCHEMBL19079935 0.93 ALOX5 (0.40) MEN1KMT2AGPR84KDM4EALDH1A1
SCHEMBL19080110 0.91 ALOX5 (0.36) MEN1KMT2AGPR84KDM4EALDH1A1
SCHEMBL17589552 0.91 GPR84 (0.39) MEN1KMT2AGPR84KDM4EALDH1A1
SCHEMBL19080001 0.89 GPR84 (0.43) MEN1KMT2AGPR84KDM4EALDH1A1
SCHEMBL17737539 0.89 ABCG2 (0.39) MEN1KMT2AGPR84KDM4EALDH1A1
SCHEMBL17737533 0.87 ABCG2 (0.38) MEN1KMT2AGPR84KDM4EALDH1A1
SCHEMBL17737571 0.87 GPR84 (0.36) MEN1KMT2AGPR84KDM4EALDH1A1
SCHEMBL19080127 0.87 ABCG2 (0.41) MEN1KMT2AGPR84KDM4EALDH1A1
SCHEMBL17737570 0.86 ALOX5 (0.40) MEN1KMT2AGPR84KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 MEN1 389/4885KMT2A 2042/4885GPR84 2425/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 MEN1 389/4885KMT2A 2042/4885GPR84 2425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.